Please login to the form below

Not currently logged in
Email:
Password:

Interleukin-11 inhibitor

This page shows the latest Interleukin-11 inhibitor news and features for those working in and with pharma, biotech and healthcare.

Boehringer bolsters NASH pipeline with Enleofen link-up

Boehringer bolsters NASH pipeline with Enleofen link-up

Boehringer Ingelheim has added another platform in its fibrotic disease R&D, partnering with Enleofen on preclinical-stage interleukin-11 inhibitors with potential in non-alcoholic steatohepatitis (NASH). ... The German pharma group has acquired

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 950 experts delivering world-class...

Latest intelligence

William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...
Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...